Nivolumab ± Ipilimumab in Patients With Pretreated Advanced Neuroendocrine Carcinoma: The GCO-001 NIPINEC Randomized Phase II Trial.

Journal:

Journal of Clinical Oncology

Published:

2026-03-04

DOI:

10.1200/jco-25-01657

Affiliations:

31

Authors:

30

Go to article

Institutions	Authors	Share
Lyon University Hospital (HCL), France	2.000000	0.07
CHU Caen, France	2.000000	0.07
Bichat-Claude Bernard Hospital, France	2.000000	0.07
French Cooperative Thoracic Group (IFCT), France	2.000000	0.07
Mutualiste Montsouris Institute (IMM), France	1.000000	0.03
Centre Antoine-Lacassagne (CAL), France	1.000000	0.03
CHU Limoges, France	1.000000	0.03
Dijon University Hospital, France	1.000000	0.03
Centre Hospitalier Avignon, France	1.000000	0.03
Cancer Research Center of Lyon (CRCL), France	1.000000	0.03
CHU de Bordeaux, France	1.000000	0.03
Centre Léon Bérard (CLB), France	1.000000	0.03
CHU de Poitiers, France	1.000000	0.03
Rouen University Hospital-Charles Nicolle (CHU de Rouen), France	1.000000	0.03
Centre Georges-François Leclerc (CGFL), France	1.000000	0.03
Unité Mixte de Recherche RIGHT, France	1.000000	0.03
Lorraine Institute of Oncology (ICL), France	1.000000	0.03
Toulouse University Hospital (CHU-Toulouse), France	1.000000	0.03
Hôpital Édouard Herriot, HCL, France	1.000000	0.03
Hôpital Privé Jean Mermoz, France	1.000000	0.03
Centre Oscar Lambret, France	1.000000	0.03
Laboratory of Electronics, Information and Image (Le2i), France	1.000000	0.03
Institut Paoli-Calmettes (IPC), France	1.000000	0.03
Hôpital National d’Instruction des Armées Sainte-Anne (HNIA Sainte-Anne), France	1.000000	0.03
Oncogenesis Stress Signaling (OSS), France	0.500000	0.02
Rennes University Hospital (CHU Rennes), France	0.500000	0.02
Institut du Thorax Curie-Montsouris, France	0.500000	0.02
University of Versailles Saint-Quentin-en-Yvelines (UVSQ), France	0.500000	0.02

Interested in Clinical Sciences?